BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 11207626)

  • 1. Growth hormone and the heart.
    Colao A; Marzullo P; Di Somma C; Lombardi G
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):137-54. PubMed ID: 11207626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and cardiac function.
    Lombardi G; Di Somma C; Marzullo P; Cerbone G; Colao A
    Ann Endocrinol (Paris); 2000 Feb; 61(1):16-21. PubMed ID: 10790587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiological aspects of growth hormone and insulin-like growth factor-I.
    Lombardi G; Colao A; Cuocolo A; Longobardi S; Di Somma C; Orio F; Merola B; Nicolai E; Salvatore M
    J Pediatr Endocrinol Metab; 1997; 10(6):553-60. PubMed ID: 9467124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
    Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
    J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone and the heart.
    SaccĂ  L; Cittadini A; Fazio S
    Endocr Rev; 1994 Oct; 15(5):555-73. PubMed ID: 7843068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heart: an end-organ of GH action.
    Colao A; Vitale G; Pivonello R; Ciccarelli A; Di Somma C; Lombardi G
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S93-101. PubMed ID: 15339252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone on cardiac function.
    Lombardi G; Colao A; Ferone D; Marzullo P; Orio F; Longobardi S; Merola B
    Horm Res; 1997; 48 Suppl 4():38-42. PubMed ID: 9350445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of growth hormone on cardiovascular health and disease.
    Colao A; Di Somma C; Vitale G; Filippella M; Lombardi G
    Treat Endocrinol; 2003; 2(5):347-56. PubMed ID: 15981951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is growth hormone good for the heart?
    Silverman BL; Friedlander JR
    J Pediatr; 1997 Jul; 131(1 Pt 2):S70-4. PubMed ID: 9255233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of growth hormone treatment: potential risks and benefits.
    Colao A
    Horm Res; 2004; 62 Suppl 3():42-50. PubMed ID: 15539798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and the cardiovascular function.
    Svensson J; Tivesten A; Isgaard J
    Minerva Endocrinol; 2005 Mar; 30(1):1-13. PubMed ID: 15877009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    SaccĂ  L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac abnormalities in acromegaly. Pathophysiology and implications for management.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Treat Endocrinol; 2004; 3(5):309-18. PubMed ID: 15330678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Morte AM; Pivonello R; Nicolai E; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):447-55. PubMed ID: 10762287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.